Dr Brendan Nolan
Senior Research Fellow
Department of Medicine
59 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Utilization and treatment patterns of subsidized gender affirming hormone therapy in Australian trans and gender diverse people from 2013–2023
DOI: 10.1080/26895269.2026.26904032026
Journal article
Initiation and Maintenance of Low-Dose Transdermal Testosterone in Non-Binary Individuals: A Retrospective Audit
DOI: 10.1111/cen.701102026
Journal article
THE EFFECTS OF GENDER-AFFIRMING HORMONE THERAPY ON BODY COMPOSITION IN TRANSGENDER INDIVIDUALS: A 24-MONTH PROSPECTIVE STUDY
DOI: 10.31189/2165-7629-15-s2.1812026
Journal article
All-cause and cause-specific mortality among transgender and gender diverse people: a nationwide cohort study in Australia
DOI: 10.1016/j.lanwpc.2026.1018132026
Research grants (other domestic)
LGBTQ+ Economists and Allies in Asia-Pacific (LEAP) Summit: Advancing LGBTQ+ Equity in Workplaces, Markets, and Society
2025
Research grants (ARC, NHMRC, MRFF)
Improving Health Outcomes for Transgender Women
2023
Research grants (other domestic)
Short-Term Effects of Micronised Progesterone in Transgender Individuals: A Randomised, Placebo-Controlled Cross-Over Trial
RECENT SCHOLARLY WORKS
2026
Journal article
Mental health treatment among transgender and gender diverse people following gender affirming hormone therapy: evidence from whole-of-population Australian administrative data
DOI: 10.1016/j.eclinm.2026.1037652026
Journal article
Mental health treatment following gender-affirming surgeries: Evidence from longitudinal Australian administrative data
DOI: 10.1080/26895269.2026.26181332025
Journal article
Temporal trends in gender-affirming hormone therapy initiation: evidence from whole-of-population Australian administrative data
DOI: 10.1111/imj.701942025
Journal article
Author reply to McDonough
DOI: 10.1111/imj.700402025
Journal article
Laboratory Monitoring in Transgender and Gender-Diverse Individuals
DOI: 10.1093/clinchem/hvaf0012025
Journal article
Approach to prolactin monitoring and hyperprolactinaemia in transgender and gender-diverse individuals undergoing gender affirming hormone therapy
DOI: 10.3389/fendo.2025.1608108